Company Overview and News

RungePincockMinaroo Ltd raises $13M opening door for acquisitions

RungePincockMinaroo Ltd (ASX:RUL) has successfully completed a placement raising $13 million through the issue of 28.9 million shares priced at $0.45 to institutional and sophisticated investors. RUL is the world’s largest publicly traded independent group of mining technical experts operating in 18 locations across 12 countries. It is a global leader in the provision of resources related software and advisory services.

RungePincockMinarco Ltd to reveal raising

RungePincockMinarco Ltd (ASX:RUL) has been granted a trading halt by the ASX this morning, pending details of a capital raising. The halt will remain in place until the opening of trade on Wednesday 28th September 2016, or earlier if an announcement is made to the market.

RungePincockMinarco Ltd acquires mining software company

RungePincockMinarco Ltd (ASX:RUL) will cast a wider net in the mining software industry after entering into an agreement to acquire 100% of iSolutions, a global mining asset management software company. The consideration for the transaction is $8 million, followed by earn out payments of $6.5 million over three years based on the achievement of performance targets. RUL will also issue 9,166,666 shares to the shareholders of iSolutions which will be held in escrow for 12 months.

RungePincockMinarco Ltd granted ASX halt pending acquisition update

RungePincockMinarco Ltd (ASX:RUL) has been granted a trading a trading halt by the ASX, pending an update on the proposed acquisition of a private software company. The halt will remain in place until the opening of trade on Wednesday 18th May 2016, or earlier if an announcement is made to the market.

Trading Update


Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

20h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

20h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...